J&J Unit's $147M Catheter Antitrust Loss Tripled To $442M

Johnson & Johnson health tech unit Biosense Webster's bill in an antitrust trial was upped from $147 million to $442 million after a California federal jury found it stifled competition by...

Already a subscriber? Click here to view full article